MedPlus Health Services Limited (MEDPLUS) Earnings Call Transcripts

MedPlus Health Services Limited's Latest Earnings Call - Q4 FY2026

MedPlus Health Services Limited reported its Q4 FY '26 earnings, highlighting a strong performance with consolidated revenue of INR 18,644 million and operating EBITDA of INR 1,076 million, representing a 5.8% margin. Revenue from pharmacy operations grew by 23.4% year-over-year. The company plans to open 800 net new stores in FY '27, signaling continued expansion. Management maintained guidance for private label growth, indicating a stable outlook for margins.

Reported metrics

Guidance from management

Management plans to open 800 net new stores in FY '27 and aims to maintain current profitability levels while growing private label contributions. No specific guidance on margin expansion was provided.

What management said

Sure. Thank you for your question. In terms of our store closures, this quarter, we had a few stores also closed down, which relates to the performance. We waited for 3-year plus stores and where we felt that we were not able to revise them to the level of the company's expectation, around 26 to 27 stores we closed down. Rest all, we have given the reasons in the investor deck.

So I think that guidance continues to be intact. What we did for the last 2 quarters is stabilize the overall growth where we also had to balance out between the branded products as well as the private label sales where we had informed the investors that we were restructuring the incentives. Now we have seen that it's working the way we expect it, and we'll be back to the trajectory where we had promised that every q...

What analysts pressed on

Analysts expressed concerns about the increasing trend in store closures and the impact of the franchisee model on profitability. Questions were raised about the sustainability of private label growth and the company's capital allocation strategy.

Main topics on the call

• Store Expansion — MedPlus opened 295 outlets and closed 77 stores in Q4, resulting in a net addition of 218 stores. For FY '27, the company plans to open 800 net new stores, including franchisee outlets. "We have enough headroom," said ma...
• Private Label Sales — Private label sales constituted 22% of total revenues in Q4 FY '26. Management reiterated the guidance of increasing private label sales by 20 to 30 basis points each quarter, aiming to balance between branded products a...
• Franchisee Model — MedPlus expanded its franchisee model, with around 300 franchisee stores added in FY '26. Management stated, "Right from day 1, we are in [indiscernible]" regarding profitability of franchisee stores.
• Operating Margins — Store-level EBITDA margin for stores older than 12 months was 13.1%, with operating EBITDA margin at 6.7%. Management plans to maintain current profitability levels while growing private label contributions.

Read the full MedPlus Health Services Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 13 MedPlus Health Services Limited earnings call transcripts on record, spanning February 16, 2022 to July 22, 2026. Based on this history, MedPlus Health Services Limited reports semi-annually. The most recent call on file is dated July 22, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MEDPLUS

Exchange

NSEI

Country

IN

Sector

Consumer Staples

Industry

Consumer Staples Distribution and Retail

Calls on record

13

First call

February 16, 2022

Most recent

July 22, 2026

Reporting cadence

semi-annually